BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6816017)

  • 21. Cascade filtration with reverse rinse of the secondary filter.
    Valbonesi M; Lercari G; Angelini G; Malfanti L; Ferrari M; Russo E; Nati S
    J Clin Apher; 1987; 3(4):240-3. PubMed ID: 3119576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and clinical evaluation of a new cellulose diacetate secondary filter for cascade filtration.
    Valbonesi M; Tarantino M; Montani F; Florio G; Romorini A
    Int J Artif Organs; 1985 Mar; 8(2):105-8. PubMed ID: 3921467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperviscosity in plasma cell dyscrasias.
    Kwaan HC
    Clin Hemorheol Microcirc; 2013; 55(1):75-83. PubMed ID: 23455837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Polychimiotherapy and Waldenström's macroglobulinemia (author's transl)].
    Barrier J; Grolleau JY; Renault JJ; Ozanne P; Bouret O
    Sem Hop; 1979 Dec 8-15; 55(41-42):1925-6. PubMed ID: 231315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of plasma exchange in treating kidney failure from paraproteinemic diseases].
    Camerone G; Banfi L; Ferrari A; Garelli S; Valbonesi M
    Riv Emoter Immunoematol; 1980; 27(3-4):168-74. PubMed ID: 7339846
    [No Abstract]   [Full Text] [Related]  

  • 26. A method for the study of cryoglobulin solubilization curves at 37 degrees C. Preliminary studies and application to plasma exchange in cryoglobulinemic syndromes.
    Valbonesi M; Florio G; Montani F; Mosconi L
    Int J Artif Organs; 1983 Mar; 6(2):87-90. PubMed ID: 6840897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic apheresis for the renal complications of multiple myeloma and the dysglobulinemias.
    Kaplan AA
    Ther Apher; 2001 Jun; 5(3):171-5. PubMed ID: 11467752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of systemic manifestations of cryoglobulinemia. Treatment with melphalan and prednisone.
    Ristow SC; Griner PF; Abraham GN; Shoulson I
    Arch Intern Med; 1976 Apr; 136(4):467-70. PubMed ID: 1267555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal cryoglobulinemia, livedo reticularis, and renal failure.
    Relia N; Gokden N; Kulshrestha S; Swaminathan S
    Kidney Int; 2012 Jul; 82(1):118. PubMed ID: 22699387
    [No Abstract]   [Full Text] [Related]  

  • 30. [Erythrocyte aggregation in patients treated by plasma exchange or plasma administration].
    Schooneman F; Stoltz JF
    Ann Med Interne (Paris); 1994; 145(5):361-4. PubMed ID: 7985950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged plasma exchange in the treatment of renal involvement in essential mixed cryoglobulinemia.
    Bombardieri S; Ferri C; Paleologo G; Bibolotti E; Camici M; Fosella PV; Pasero G; Moriconi L
    Int J Artif Organs; 1983 Jul; 6 Suppl 1():47-50. PubMed ID: 6642737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
    Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
    Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hyperviscosity syndrome and Waldenström's macroglobulinemia].
    Shida M; Baba M; Sawada S
    Nihon Rinsho; 1992 Jan; 50 Suppl():298-303. PubMed ID: 1578695
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasmapheresis in the dysproteinemias.
    Drew MJ
    Ther Apher; 2002 Feb; 6(1):45-52. PubMed ID: 11886576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Osteonecrosis developing after rituximab-containing chemotherapy for Waldenström macroglobulinemia].
    Nakamura F; Hirai R; Higo T; Togano T; Sekine R
    Rinsho Ketsueki; 2018; 59(3):305-309. PubMed ID: 29618689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type I cryoglobulinemia: approach to management.
    Friedland ML; Strother SV
    Ann Allergy; 1981 Mar; 46(3):149-51. PubMed ID: 6781386
    [No Abstract]   [Full Text] [Related]  

  • 37. A phase II trial on alpha-interferon (alpha IFN) effect in patients with monoclonal IgM gammopathy.
    Rotoli B; De Renzo A; Frigeri F; Buffardi S; Marcenò R; Cavallaro AM; Ruggeri P; Liso V; Musto P; Andriani A
    Leuk Lymphoma; 1994 May; 13(5-6):463-9. PubMed ID: 8069191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term plasma exchange. Analysis of indications, outcome and side effects.
    Karmochkine M; Bussel A; Léon A; Jarrousse B; Baudelot J; Guillevin L
    Ann Med Interne (Paris); 1994; 145(5):373-5. PubMed ID: 7985953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal cryoglobulinemia with macroglobulinemia in a dog.
    Hurvitz AI; MacEwen EG; Middaugh CR; Litman GW
    J Am Vet Med Assoc; 1977 Mar; 170(5):511-3. PubMed ID: 403167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of multiple myeloma and macroglobulinemai Waldenström: A long-term follow-up study.
    Onodera S; Otaki M; Oikawa K; Mikami M; Sato I
    Tohoku J Exp Med; 1975 Aug; 116(4):317-25. PubMed ID: 810919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.